Stocks and Investing
Stocks and Investing
Tue, November 19, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 18, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mike Crawford Initiated (ACST) at Strong Buy and Held Target at $384 on, Nov 18th, 2019
Mike Crawford of B. Riley Securities, Initiated "Acasti Pharma Inc." (ACST) at Strong Buy and Held Target at $384 on, Nov 18th, 2019.
Mike has made no other calls on ACST in the last 4 months.
There are 2 other peers that have a rating on ACST. Out of the 2 peers that are also analyzing ACST, 0 agree with Mike's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mike
- Mayank Mamtani of "B. Riley Securities" Initiated at Strong Buy and Held Target at $372 on, Thursday, August 29th, 2019
- Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $336 on, Thursday, July 18th, 2019